NIH-funded research R01 grant

Role of TGF-beta Activation in Aortic Stenosis Progression

Official title: The Role of TGF-beta Activation and Signaling in Aortic Stenosis Progression

Funded at Oklahoma Medical Research Foundation · NIH-11234096 · Data updated 2026-11-12

A heart disease grant that studies how a blood-signal (TGF-beta) helps aortic valve disease progress, with potential implications for people living with aortic stenosis.

More Aortic Stenosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOklahoma Medical Research Foundation
NIH-funded
Lab location1 site (Oklahoma City, United States)
Project startApril 1, 2020
Project endJune 30, 2030
Funding year2026
Award (this year)$786,750
NIH project number2R01HL148123-05A1
Project IDNIH-11234096 on NIH RePORTER

Who could benefit from this research

Could help

Patients with aortic stenosis or related valve disease, especially in older adults, may be relevant for future translational or clinical follow-up.

Less likely to help

People without aortic valve disease or those not eligible for future translational studies may not benefit directly.

What this research studies

This project looks at how mechanical forces in the heart activate TGF-beta, which may drive worsening aortic stenosis and related heart failure. Researchers use mouse models that develop aortic stenosis and anemia-induced changes to understand the pathways that lead to valve disease and, potentially, acquired von Willebrand syndrome. They are exploring how activated TGF-beta signaling inside valve cells correlates with disease progression and symptoms. The study aims to uncover mechanisms that could later guide new therapies or diagnostic approaches for patients with AS and related conditions.

Why it matters

Potential benefit: If successful, findings could inform earlier diagnosis and new treatment targets to slow AS progression and reduce complications like heart failure and bleeding disorders.

How similar studies have gone: Prior work has linked TGF-beta signaling to valve disease progression in animal models, with ongoing exploration needed for human relevance.

Where this research is happening

  • Oklahoma Medical Research Foundation
    Oklahoma City, United States
    Active

Researchers

  • Principal investigator: Ahamed, Jasimuddin — Oklahoma Medical Research Foundation
  • Study coordinator: Ahamed, Jasimuddin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.